Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal eye physiology (HP:0012373)help
Parent Node:
expand
Abnormality of vision (HP:0000504)help
..Starting node
..expand
Visual loss (HP:0000572)help
Term ID: 572
Name: Visual loss
Synonym: Loss of vision; Vision loss; Visual loss
Definition: Loss of visual acuity (implying that vision was better at a certain time point in life). Otherwise the term reduced visual acuity should be used (or a subclass of that).
Comments:
Reference: HP:0000572
Genes and Diseases:
 
       Child Nodes:
........expandProgressive visual loss (HP:0000529) help
................... HP:0007924 Slow decrease in visual acuity
........expandNonprogressive visual loss (HP:0200068) help

 Sister Nodes: 
..expandAbnormality of binocular vision (HP:0011514) help
..expandAmaurosis fugax (HP:0100576) help
..expandBlurred vision (HP:0000622) help
..expandBradyopsia (HP:0030511) help
..expandColor vision defect (HP:0000551) help
..expandDifficulty adjusting to changes in luminance (HP:0030512) help
..expandHemeralopia (HP:0012047) help
..expandMetamorphopsia (HP:0012508) help
..expandNyctalopia (HP:0000662) help
..expandPhotophobia (HP:0000613) help
..expandPhotopsia (HP:0030786) help
..expandPoor visual behavior for age (HP:0025152) help
..expandReduced visual acuity (HP:0007663) help
..expandVisual field defect (HP:0001123) help
..expandVisual impairment (HP:0000505) help
..expandVitreous floaters (HP:0100832) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0000572HP:0000572Visual loss0ABCA4 CL E G H2434OMIM:604116CONE-ROD DYSTROPHY 3; CORD3826
HP:0000572HP:0000572Visual loss0ABCD1 CL E G H21561OMIM:300100Adrenoleukodystrophy.135
HP:0000572HP:0000572Visual loss0ADAMTS10 CL E G H8179413201ORPHA:3449Weill-Marchesani syndromeHP:0040283 - Occasional63
HP:0000572HP:0000572Visual loss0ADGRV1 CL E G H8405917416ORPHA:231178Usher syndrome type 2HP:0040281 - Very frequent530
HP:0000572HP:0000572Visual loss0AGBL1 CL E G H12362426504ORPHA:98974Fuchs endothelial corneal dystrophy3
HP:0000572HP:0000572Visual loss0AGTPBP1 CL E G H2328717258ORPHA:2254Pontocerebellar hypoplasia type 11
HP:0000572HP:0000572Visual loss0AHI1 CL E G H5480621575ORPHA:220493Joubert syndrome with ocular defectHP:0040283 - Occasional175
HP:0000572HP:0000572Visual loss0AIP CL E G H9049358ORPHA:2965Prolactinoma95
HP:0000572HP:0000572Visual loss0AKT1 CL E G H207391ORPHA:2495Meningioma54
HP:0000572HP:0000572Visual loss0ALMS1 CL E G H7840428ORPHA:64Alström syndromeHP:0040281 - Very frequent404
HP:0000572HP:0000572Visual loss0ALMS1 CL E G H7840428OMIM:203800Alstrom syndrome.404
HP:0000572HP:0000572Visual loss0ALPK1 CL E G H8021620917OMIM:614979Splenomegaly, cytopenia, and vision loss.
HP:0000572HP:0000572Visual loss0ANKRD55 CL E G H7972225681ORPHA:85410Oligoarticular juvenile idiopathic arthritisHP:0040283 - Occasional
HP:0000572HP:0000572Visual loss0APOE CL E G H348613OMIM:603075Macular degeneration, age-related, 139
HP:0000572HP:0000572Visual loss0ARL3 CL E G H403694OMIM:618161JOUBERT SYNDROME 35; JBTS351
HP:0000572HP:0000572Visual loss0ARSG CL E G H2290124102ORPHA:231183Usher syndrome type 3HP:0040281 - Very frequent
HP:0000572HP:0000572Visual loss0ATP1A3 CL E G H478801OMIM:601338Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss.150
HP:0000572HP:0000572Visual loss0ATP6 CL E G H45087414ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000572Visual loss0ATP6 CL E G H45087414OMIM:535000Leber optic atrophy.
HP:0000572HP:0000572Visual loss0ATXN7 CL E G H631410560OMIM:164500Spinocerebellar ataxia 7 opca III opca with retinal degeneration opca with macular degeneration and external ophthalmoplegia autosomal dominant cerebellar ataxia, type II adca, type II8
HP:0000572HP:0000572Visual loss0ATXN7 CL E G H631410560ORPHA:94147Spinocerebellar ataxia type 7HP:0040282 - Frequent8
HP:0000572HP:0000572Visual loss0BAP1 CL E G H8314950ORPHA:2495Meningioma184
HP:0000572HP:0000572Visual loss0BAP1 CL E G H8314950ORPHA:39044Uveal melanomaHP:0040281 - Very frequent184
HP:0000572HP:0000572Visual loss0BCOR CL E G H5488020893OMIM:300166Microphthalmia, syndromic 2.101
HP:0000572HP:0000572Visual loss0BRAF CL E G H6731097OMIM:115150Cardiofaciocutaneous syndrome 1276
HP:0000572HP:0000572Visual loss0BRAF CL E G H6731097ORPHA:54595Craniopharyngioma276
HP:0000572HP:0000572Visual loss0BTD CL E G H6861122ORPHA:79241Biotinidase deficiency223
HP:0000572HP:0000572Visual loss0BTD CL E G H6861122OMIM:253260Biotinidase deficiencymultiple carboxylase deficiency, late-onset.223
HP:0000572HP:0000572Visual loss0C19ORF12 CL E G H8363625443OMIM:614298Neurodegeneration with brain iron accumulation 4114
HP:0000572HP:0000572Visual loss0C1QTNF5 CL E G H11490214344ORPHA:67042Late-onset retinal degenerationHP:0040282 - Frequent20
HP:0000572HP:0000572Visual loss0C1QTNF5 CL E G H11490214344OMIM:605670Late-Onset retinal degeneration.20
HP:0000572HP:0000572Visual loss0CA2 CL E G H7601373OMIM:259730Osteopetrosis, autosomal recessive 3.29
HP:0000572HP:0000572Visual loss0CARS2 CL E G H7958725695ORPHA:477774Combined oxidative phosphorylation defect type 2735
HP:0000572HP:0000572Visual loss0CCND1 CL E G H5951582ORPHA:892Von Hippel-Lindau diseaseHP:0040283 - Occasional1
HP:0000572HP:0000572Visual loss0CD247 CL E G H9191677ORPHA:85410Oligoarticular juvenile idiopathic arthritisHP:0040283 - Occasional8
HP:0000572HP:0000572Visual loss0CDH23 CL E G H6407213733ORPHA:2965Prolactinoma636
HP:0000572HP:0000572Visual loss0CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenoma636
HP:0000572HP:0000572Visual loss0CDH23 CL E G H6407213733ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent636
HP:0000572HP:0000572Visual loss0CDHR1 CL E G H9221114550OMIM:613660CONE-ROD DYSTROPHY 15; CORD15147
HP:0000572HP:0000572Visual loss0CEP120 CL E G H15324126690ORPHA:220493Joubert syndrome with ocular defectHP:0040283 - Occasional7
HP:0000572HP:0000572Visual loss0CEP164 CL E G H2289729182ORPHA:3156Senior-Loken syndrome34
HP:0000572HP:0000572Visual loss0CEP290 CL E G H8018429021ORPHA:3156Senior-Loken syndrome342
HP:0000572HP:0000572Visual loss0CEP41 CL E G H9568112370ORPHA:220493Joubert syndrome with ocular defectHP:0040283 - Occasional90
HP:0000572HP:0000572Visual loss0CEP78 CL E G H8413125740ORPHA:231183Usher syndrome type 3HP:0040281 - Very frequent9
HP:0000572HP:0000572Visual loss0CFAP418 CL E G H15765727232OMIM:614500Cone-Rod dystrophy 16
HP:0000572HP:0000572Visual loss0CFH CL E G H30754883OMIM:126700Basal laminar drusen86
HP:0000572HP:0000572Visual loss0CFH CL E G H30754883ORPHA:75376Familial drusenHP:0040281 - Very frequent86
HP:0000572HP:0000572Visual loss0CFHR1 CL E G H30784888OMIM:603075Macular degeneration, age-related, 1
HP:0000572HP:0000572Visual loss0CFHR3 CL E G H1087816980OMIM:603075Macular degeneration, age-related, 1
HP:0000572HP:0000572Visual loss0CFI CL E G H34265394ORPHA:75376Familial drusenHP:0040281 - Very frequent57
HP:0000572HP:0000572Visual loss0CFI CL E G H34265394OMIM:615439Macular degeneration, age-related, 1357
HP:0000572HP:0000572Visual loss0CHM CL E G H11211940ORPHA:180Choroideremia47
HP:0000572HP:0000572Visual loss0CHM CL E G H11211940OMIM:303100CHOROIDEREMIA47
HP:0000572HP:0000572Visual loss0CIB2 CL E G H1051824579ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent15
HP:0000572HP:0000572Visual loss0CLCN7 CL E G H11862025OMIM:166600Osteopetrosis, autosomal dominant 2.102
HP:0000572HP:0000572Visual loss0CLN3 CL E G H12012074OMIM:204200Ceroid lipofuscinosis, neuronal, 3216
HP:0000572HP:0000572Visual loss0CLN3 CL E G H12012074ORPHA:228346CLN3 disease216
HP:0000572HP:0000572Visual loss0CLN5 CL E G H12032076OMIM:256731Ceroid lipofuscinosis, neuronal, 5141
HP:0000572HP:0000572Visual loss0CLN6 CL E G H549822077OMIM:601780Ceroid lipofuscinosis, neuronal, 6143
HP:0000572HP:0000572Visual loss0CLN8 CL E G H20552079OMIM:600143Ceroid lipofuscinosis, neuronal, 8111
HP:0000572HP:0000572Visual loss0CLN8 CL E G H20552079ORPHA:1947Progressive epilepsy-intellectual disability syndrome, Finnish type111
HP:0000572HP:0000572Visual loss0CLRN1 CL E G H740112605ORPHA:231183Usher syndrome type 3HP:0040281 - Very frequent60
HP:0000572HP:0000572Visual loss0COL17A1 CL E G H13082194ORPHA:293381Epithelial recurrent erosion dystrophy129
HP:0000572HP:0000572Visual loss0COL18A1 CL E G H807812195ORPHA:1571Knobloch syndromeHP:0040282 - Frequent177
HP:0000572HP:0000572Visual loss0COL2A1 CL E G H12802200ORPHA:90653Stickler syndrome type 1HP:0040283 - Occasional284
HP:0000572HP:0000572Visual loss0COL7A1 CL E G H12942214ORPHA:89842Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate formHP:0040283 - Occasional263
HP:0000572HP:0000572Visual loss0COL7A1 CL E G H12942214ORPHA:79408Autosomal recessive generalized dystrophic epidermolysis bullosa, severe formHP:0040283 - Occasional263
HP:0000572HP:0000572Visual loss0COL8A2 CL E G H12962216ORPHA:98974Fuchs endothelial corneal dystrophy3
HP:0000572HP:0000572Visual loss0COQ2 CL E G H2723525223OMIM:607426Coenzyme Q10 deficiency, primary, 1.54
HP:0000572HP:0000572Visual loss0COX1 CL E G H45127419ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000572Visual loss0COX1 CL E G H45127419ORPHA:550MELASHP:0040282 - Frequent
HP:0000572HP:0000572Visual loss0COX2 CL E G H45137421ORPHA:550MELASHP:0040282 - Frequent
HP:0000572HP:0000572Visual loss0COX3 CL E G H45147422ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000572Visual loss0COX3 CL E G H45147422OMIM:535000Leber optic atrophy.
HP:0000572HP:0000572Visual loss0COX3 CL E G H45147422ORPHA:550MELASHP:0040282 - Frequent
HP:0000572HP:0000572Visual loss0COX6B1 CL E G H13402280OMIM:619051MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7; MC4DN710
HP:0000572HP:0000572Visual loss0COX7B CL E G H13492291ORPHA:2556Microphthalmia with linear skin defects syndromeHP:0040283 - Occasional6
HP:0000572HP:0000572Visual loss0CSPP1 CL E G H7984826193ORPHA:397715Joubert syndrome with Jeune asphyxiating thoracic dystrophyHP:0040283 - Occasional57
HP:0000572HP:0000572Visual loss0CTNNB1 CL E G H14992514ORPHA:54595Craniopharyngioma88
HP:0000572HP:0000572Visual loss0CTSD CL E G H15092529OMIM:610127Ceroid lipofuscinosis, neuronal, 10.159
HP:0000572HP:0000572Visual loss0CYP1B1 CL E G H15452597ORPHA:98976Congenital glaucomaHP:0040283 - Occasional101
HP:0000572HP:0000572Visual loss0CYP4V2 CL E G H28544023198OMIM:210370Bietti crystalline corneoretinal dystrophy126
HP:0000572HP:0000572Visual loss0CYSLTR2 CL E G H5710518274ORPHA:39044Uveal melanomaHP:0040281 - Very frequent1
HP:0000572HP:0000572Visual loss0CYTB CL E G H45197427ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000572Visual loss0CYTB CL E G H45197427OMIM:535000Leber optic atrophy.
HP:0000572HP:0000572Visual loss0DCN CL E G H16342705OMIM:610048Corneal dystrophy, congenital stromal31
HP:0000572HP:0000572Visual loss0DNAJC30 CL E G H8427716410ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000572Visual loss0DNM1L CL E G H100592973OMIM:610708Optic atrophy 594
HP:0000572HP:0000572Visual loss0EFEMP1 CL E G H22023218ORPHA:75376Familial drusenHP:0040281 - Very frequent54
HP:0000572HP:0000572Visual loss0ELMO2 CL E G H6391617233OMIM:606893Vascular malformation, primary intraosseous.3
HP:0000572HP:0000572Visual loss0EPM2A CL E G H79573413OMIM:254780Myoclonic epilepsy of lafora.83
HP:0000572HP:0000572Visual loss0EPRS1 CL E G H20583418OMIM:617951Leukodystrophy, hypomyelinating, 15
HP:0000572HP:0000572Visual loss0ESPN CL E G H8371513281ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent33
HP:0000572HP:0000572Visual loss0EXOSC3 CL E G H5101017944ORPHA:2254Pontocerebellar hypoplasia type 138
HP:0000572HP:0000572Visual loss0EXOSC8 CL E G H1134017035ORPHA:2254Pontocerebellar hypoplasia type 14
HP:0000572HP:0000572Visual loss0EXOSC9 CL E G H53939137ORPHA:2254Pontocerebellar hypoplasia type 1
HP:0000572HP:0000572Visual loss0FA2H CL E G H7915221197ORPHA:329308Fatty acid hydroxylase-associated neurodegeneration76
HP:0000572HP:0000572Visual loss0FBN1 CL E G H22003603ORPHA:3449Weill-Marchesani syndromeHP:0040283 - Occasional1361
HP:0000572HP:0000572Visual loss0FGFR2 CL E G H22633689ORPHA:93259Pfeiffer syndrome type 2HP:0040283 - Occasional175
HP:0000572HP:0000572Visual loss0FLVCR1 CL E G H2898224682ORPHA:88628Posterior column ataxia-retinitis pigmentosa syndromeHP:0040282 - Frequent111
HP:0000572HP:0000572Visual loss0FOXC1 CL E G H22963800ORPHA:250923Isolated aniridiaHP:0040281 - Very frequent63
HP:0000572HP:0000572Visual loss0GALC CL E G H25814115ORPHA:206448Adult Krabbe diseaseHP:0040283 - Occasional160
HP:0000572HP:0000572Visual loss0GALC CL E G H25814115ORPHA:206436Infantile Krabbe diseaseHP:0040283 - Occasional160
HP:0000572HP:0000572Visual loss0GALC CL E G H25814115ORPHA:206443Late-infantile/juvenile Krabbe diseaseHP:0040282 - Frequent160
HP:0000572HP:0000572Visual loss0GATA2 CL E G H26244171ORPHA:3226Deafness-lymphedema-leukemia syndromeHP:0040282 - Frequent137
HP:0000572HP:0000572Visual loss0GJB2 CL E G H27064284ORPHA:477KID syndrome199
HP:0000572HP:0000572Visual loss0GJB6 CL E G H108044288ORPHA:477KID syndrome56
HP:0000572HP:0000572Visual loss0GNA11 CL E G H27674379ORPHA:39044Uveal melanomaHP:0040281 - Very frequent16
HP:0000572HP:0000572Visual loss0GNAQ CL E G H27764390ORPHA:39044Uveal melanomaHP:0040281 - Very frequent7
HP:0000572HP:0000572Visual loss0GNAS CL E G H27784392ORPHA:562McCune-Albright syndromeHP:0040284 - Very rare101
HP:0000572HP:0000572Visual loss0GUCA1A CL E G H29784678ORPHA:75377Central areolar choroidal dystrophyHP:0040282 - Frequent24
HP:0000572HP:0000572Visual loss0GUCA1A CL E G H29784678OMIM:602093Cone dystrophy 324
HP:0000572HP:0000572Visual loss0GUCY2D CL E G H30004689ORPHA:75377Central areolar choroidal dystrophyHP:0040282 - Frequent124
HP:0000572HP:0000572Visual loss0HADHA CL E G H30304801ORPHA:5Long chain 3-hydroxyacyl-CoA dehydrogenase deficiencyHP:0040282 - Frequent99
HP:0000572HP:0000572Visual loss0HARS1 CL E G H30354816ORPHA:231183Usher syndrome type 3HP:0040281 - Very frequent
HP:0000572HP:0000572Visual loss0HCCS CL E G H30524837ORPHA:2556Microphthalmia with linear skin defects syndromeHP:0040283 - Occasional11
HP:0000572HP:0000572Visual loss0HLA-A CL E G H31054931ORPHA:179Birdshot chorioretinopathyHP:0040281 - Very frequent4
HP:0000572HP:0000572Visual loss0HLA-B CL E G H31064932ORPHA:397Giant cell arteritisHP:0040283 - Occasional4
HP:0000572HP:0000572Visual loss0HLA-DRB1 CL E G H31234948ORPHA:397Giant cell arteritisHP:0040283 - Occasional2
HP:0000572HP:0000572Visual loss0HMCN1 CL E G H8387219194OMIM:603075Macular degeneration, age-related, 1262
HP:0000572HP:0000572Visual loss0HSD17B10 CL E G H30284800ORPHA:391428HSD10 disease, infantile typeHP:0040283 - Occasional19
HP:0000572HP:0000572Visual loss0HSD17B10 CL E G H30284800OMIM:300438HSD10 mitochondrial disease.19
HP:0000572HP:0000572Visual loss0HSD17B4 CL E G H32955213OMIM:261515D-bifunctional protein deficiency98
HP:0000572HP:0000572Visual loss0IFT140 CL E G H974229077OMIM:617781Retinitis pigmentosa 80148
HP:0000572HP:0000572Visual loss0IFT140 CL E G H974229077OMIM:266920Short-rib thoracic dysplasia 9 with or without polydactyly.148
HP:0000572HP:0000572Visual loss0IL2RA CL E G H35596008ORPHA:85410Oligoarticular juvenile idiopathic arthritisHP:0040283 - Occasional65
HP:0000572HP:0000572Visual loss0IL2RB CL E G H35606009ORPHA:85410Oligoarticular juvenile idiopathic arthritisHP:0040283 - Occasional
HP:0000572HP:0000572Visual loss0INPP5E CL E G H5662321474ORPHA:220493Joubert syndrome with ocular defectHP:0040283 - Occasional111
HP:0000572HP:0000572Visual loss0INVS CL E G H2713017870ORPHA:3156Senior-Loken syndrome106
HP:0000572HP:0000572Visual loss0IQCB1 CL E G H965728949ORPHA:3156Senior-Loken syndrome61
HP:0000572HP:0000572Visual loss0KARS1 CL E G H37356215OMIM:619196DEAFNESS, CONGENITAL, AND ADULT-ONSET PROGRESSIVE LEUKOENCEPHALOPATHY; DEAPLE
HP:0000572HP:0000572Visual loss0KCTD7 CL E G H15488121957OMIM:611726Epilepsy, progressive myoclonic 3, with or without intracellular inclusionsHP:0040283 - Occasional106
HP:0000572HP:0000572Visual loss0KIAA0586 CL E G H978619960ORPHA:397715Joubert syndrome with Jeune asphyxiating thoracic dystrophyHP:0040283 - Occasional24
HP:0000572HP:0000572Visual loss0KIAA1549 CL E G H5767022219OMIM:618613RETINITIS PIGMENTOSA 86; RP86
HP:0000572HP:0000572Visual loss0KIF11 CL E G H38326388ORPHA:2526Microcephaly-lymphedema-chorioretinopathy syndromeHP:0040283 - Occasional46
HP:0000572HP:0000572Visual loss0KIF1A CL E G H547888ORPHA:2836PEHO syndromeHP:0040281 - Very frequent276
HP:0000572HP:0000572Visual loss0LAMC3 CL E G H103196494OMIM:614115Cortical malformations, occipital.114
HP:0000572HP:0000572Visual loss0LCA5 CL E G H16769131923OMIM:604537Leber congenital amaurosis 5.HP:0003577 - Congenital onset70
HP:0000572HP:0000572Visual loss0LRP2 CL E G H40366694ORPHA:2143Donnai-Barrow syndrome289
HP:0000572HP:0000572Visual loss0LRP2 CL E G H40366694OMIM:222448Donnai-Barrow syndrome289
HP:0000572HP:0000572Visual loss0LSS CL E G H40476708OMIM:616509Cataract 44.2
HP:0000572HP:0000572Visual loss0LTBP2 CL E G H40536715ORPHA:98976Congenital glaucomaHP:0040283 - Occasional123
HP:0000572HP:0000572Visual loss0LTBP2 CL E G H40536715ORPHA:3449Weill-Marchesani syndromeHP:0040283 - Occasional123
HP:0000572HP:0000572Visual loss0MEN1 CL E G H42217010ORPHA:2965Prolactinoma462
HP:0000572HP:0000572Visual loss0MERTK CL E G H104617027OMIM:613862Retinitis pigmentosa 3875
HP:0000572HP:0000572Visual loss0MFN2 CL E G H992716877OMIM:601152Hereditary motor and sensory neuropathy VI203
HP:0000572HP:0000572Visual loss0MFSD8 CL E G H25647128486OMIM:610951Ceroid lipofuscinosis, neuronal, 7.120
HP:0000572HP:0000572Visual loss0MKS1 CL E G H549037121ORPHA:220493Joubert syndrome with ocular defectHP:0040283 - Occasional127
HP:0000572HP:0000572Visual loss0MMP1 CL E G H43127155ORPHA:79408Autosomal recessive generalized dystrophic epidermolysis bullosa, severe formHP:0040283 - Occasional6
HP:0000572HP:0000572Visual loss0MTTP CL E G H45477467ORPHA:14Abetalipoproteinemia81
HP:0000572HP:0000572Visual loss0MYO7A CL E G H46477606ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent516
HP:0000572HP:0000572Visual loss0MYO7A CL E G H46477606ORPHA:231178Usher syndrome type 2HP:0040281 - Very frequent516
HP:0000572HP:0000572Visual loss0MYO7A CL E G H46477606OMIM:276900Usher syndrome, type I.516
HP:0000572HP:0000572Visual loss0MYOC CL E G H46537610ORPHA:98976Congenital glaucomaHP:0040283 - Occasional47
HP:0000572HP:0000572Visual loss0NBAS CL E G H5159415625OMIM:614800Short stature, optic nerve atrophy, and pelger-huet anomaly25
HP:0000572HP:0000572Visual loss0ND1 CL E G H45357455ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000572Visual loss0ND1 CL E G H45357455OMIM:535000Leber optic atrophy.
HP:0000572HP:0000572Visual loss0ND1 CL E G H45357455ORPHA:550MELASHP:0040282 - Frequent
HP:0000572HP:0000572Visual loss0ND2 CL E G H45367456ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000572Visual loss0ND2 CL E G H45367456OMIM:535000Leber optic atrophy.
HP:0000572HP:0000572Visual loss0ND4 CL E G H45387459ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000572Visual loss0ND4 CL E G H45387459OMIM:535000Leber optic atrophy.
HP:0000572HP:0000572Visual loss0ND4 CL E G H45387459ORPHA:550MELASHP:0040282 - Frequent
HP:0000572HP:0000572Visual loss0ND4L CL E G H45397460ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000572Visual loss0ND4L CL E G H45397460OMIM:535000Leber optic atrophy.
HP:0000572HP:0000572Visual loss0ND5 CL E G H45407461ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000572Visual loss0ND5 CL E G H45407461OMIM:535000Leber optic atrophy.
HP:0000572HP:0000572Visual loss0ND5 CL E G H45407461ORPHA:550MELASHP:0040282 - Frequent
HP:0000572HP:0000572Visual loss0ND6 CL E G H45417462ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000572Visual loss0ND6 CL E G H45417462OMIM:535000Leber optic atrophy.
HP:0000572HP:0000572Visual loss0ND6 CL E G H45417462ORPHA:550MELASHP:0040282 - Frequent
HP:0000572HP:0000572Visual loss0NDUFB11 CL E G H5453920372ORPHA:2556Microphthalmia with linear skin defects syndromeHP:0040283 - Occasional3
HP:0000572HP:0000572Visual loss0NDUFS2 CL E G H47207708ORPHA:104Leber hereditary optic neuropathy65
HP:0000572HP:0000572Visual loss0NEU1 CL E G H47587758ORPHA:93400Congenital sialidosis type 2HP:0040283 - Occasional43
HP:0000572HP:0000572Visual loss0NEU1 CL E G H47587758ORPHA:93399Juvenile sialidosis type 2HP:0040283 - Occasional43
HP:0000572HP:0000572Visual loss0NEU1 CL E G H47587758OMIM:256550Neuraminidase deficiency43
HP:0000572HP:0000572Visual loss0NEU1 CL E G H47587758ORPHA:812Sialidosis type 143
HP:0000572HP:0000572Visual loss0NF1 CL E G H47637765ORPHA:9768517q11 microdeletion syndrome1952
HP:0000572HP:0000572Visual loss0NF2 CL E G H47717773ORPHA:2495Meningioma220
HP:0000572HP:0000572Visual loss0NF2 CL E G H47717773ORPHA:637Neurofibromatosis type 2HP:0040283 - Occasional220
HP:0000572HP:0000572Visual loss0NHLRC1 CL E G H37888421576OMIM:254780Myoclonic epilepsy of lafora.77
HP:0000572HP:0000572Visual loss0NHS CL E G H48107820OMIM:302350Nance-Horan syndrome.88
HP:0000572HP:0000572Visual loss0NHS CL E G H48107820ORPHA:627Nance-Horan syndromeHP:0040281 - Very frequent88
HP:0000572HP:0000572Visual loss0NOD2 CL E G H641275331ORPHA:90340Blau syndromeHP:0040283 - Occasional187
HP:0000572HP:0000572Visual loss0NOTCH3 CL E G H48547883OMIM:125310Cerebral arteriopathy, autosomal dominant, with subcortical infarctsand leukoencephalopathyHP:0040283 - Occasional144
HP:0000572HP:0000572Visual loss0NPHP1 CL E G H48677905ORPHA:3156Senior-Loken syndrome85
HP:0000572HP:0000572Visual loss0NPHP3 CL E G H270317907ORPHA:3156Senior-Loken syndrome157
HP:0000572HP:0000572Visual loss0NPHP4 CL E G H26173419104ORPHA:3156Senior-Loken syndrome220
HP:0000572HP:0000572Visual loss0OAT CL E G H49428091ORPHA:414Gyrate atrophy of choroid and retina94
HP:0000572HP:0000572Visual loss0OPA1 CL E G H49768140ORPHA:1215Autosomal dominant optic atrophy plus syndrome214
HP:0000572HP:0000572Visual loss0OPA1 CL E G H49768140OMIM:210000Behr syndrome214
HP:0000572HP:0000572Visual loss0P4HA2 CL E G H89748547ORPHA:397Giant cell arteritisHP:0040283 - Occasional3
HP:0000572HP:0000572Visual loss0PAK2 CL E G H50628591ORPHA:1571Knobloch syndromeHP:0040282 - Frequent
HP:0000572HP:0000572Visual loss0PAX6 CL E G H50808620ORPHA:250923Isolated aniridiaHP:0040281 - Very frequent194
HP:0000572HP:0000572Visual loss0PCDH15 CL E G H6521714674ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent352
HP:0000572HP:0000572Visual loss0PCYT1A CL E G H51308754OMIM:608940Spondylometaphyseal dysplasia with cone-rod dystrophy11
HP:0000572HP:0000572Visual loss0PDGFB CL E G H51558800ORPHA:2495Meningioma9
HP:0000572HP:0000572Visual loss0PDZD7 CL E G H7995526257ORPHA:231178Usher syndrome type 2HP:0040281 - Very frequent40
HP:0000572HP:0000572Visual loss0PEX13 CL E G H51948855OMIM:614885Peroxisome biogenesis disorder 11B.66
HP:0000572HP:0000572Visual loss0PEX7 CL E G H51918860ORPHA:773Refsum disease72
HP:0000572HP:0000572Visual loss0PGK1 CL E G H52308896OMIM:300653Phosphoglycerate kinase 1 deficiencyHP:0040283 - Occasional21
HP:0000572HP:0000572Visual loss0PHYH CL E G H52648940ORPHA:773Refsum disease45
HP:0000572HP:0000572Visual loss0PIK3CA CL E G H52908975ORPHA:2495Meningioma162
HP:0000572HP:0000572Visual loss0PLA2G6 CL E G H83989039OMIM:256600Neurodegeneration with brain iron accumulation 2A.133
HP:0000572HP:0000572Visual loss0PMPCB CL E G H95129119OMIM:617954Multiple mitochondrial dysfunctions syndrome 6HP:0040284 - Very rare
HP:0000572HP:0000572Visual loss0PNPLA6 CL E G H1090816268OMIM:215470Boucher-Neuhauser syndrome103
HP:0000572HP:0000572Visual loss0POLA1 CL E G H54229173OMIM:301220PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED; PDR2
HP:0000572HP:0000572Visual loss0POLG CL E G H54289179OMIM:203700Mitochondrial DNA depletion syndrome 4A (Alpers type).464
HP:0000572HP:0000572Visual loss0POLG2 CL E G H112329180OMIM:619425MITOCHONDRIAL DNA DEPLETION SYNDROME 16B (NEUROOPHTHALMIC TYPE); MTDPS16B45
HP:0000572HP:0000572Visual loss0PPT1 CL E G H55389325OMIM:256730Ceroid lipofuscinosis, neuronal, 1172
HP:0000572HP:0000572Visual loss0PRDM5 CL E G H111079349ORPHA:90354Brittle cornea syndromeHP:0040282 - Frequent58
HP:0000572HP:0000572Visual loss0PRPH2 CL E G H59619942ORPHA:75377Central areolar choroidal dystrophyHP:0040282 - Frequent159
HP:0000572HP:0000572Visual loss0PRPH2 CL E G H59619942ORPHA:52427Retinitis punctata albescens159
HP:0000572HP:0000572Visual loss0PRPS1 CL E G H56319462OMIM:301835Arts syndrome.49
HP:0000572HP:0000572Visual loss0PRPS1 CL E G H56319462OMIM:311070Charcot-Marie-Tooth disease, X-linked recessive, 549
HP:0000572HP:0000572Visual loss0PSAP CL E G H56609498ORPHA:206436Infantile Krabbe diseaseHP:0040283 - Occasional81
HP:0000572HP:0000572Visual loss0PTPN2 CL E G H57719650ORPHA:85410Oligoarticular juvenile idiopathic arthritisHP:0040283 - Occasional
HP:0000572HP:0000572Visual loss0PTPN22 CL E G H261919652ORPHA:397Giant cell arteritisHP:0040283 - Occasional3
HP:0000572HP:0000572Visual loss0PTPN22 CL E G H261919652ORPHA:85410Oligoarticular juvenile idiopathic arthritisHP:0040283 - Occasional3
HP:0000572HP:0000572Visual loss0RAX2 CL E G H8483918286OMIM:610381Cone-Rod dystrophy 1152
HP:0000572HP:0000572Visual loss0RDH11 CL E G H5110917964ORPHA:436245Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome2
HP:0000572HP:0000572Visual loss0RDH5 CL E G H59599940ORPHA:52427Retinitis punctata albescens32
HP:0000572HP:0000572Visual loss0RHO CL E G H601010012ORPHA:52427Retinitis punctata albescens107
HP:0000572HP:0000572Visual loss0RLBP1 CL E G H601710024ORPHA:85128Bothnia retinal dystrophy47
HP:0000572HP:0000572Visual loss0RLBP1 CL E G H601710024ORPHA:52427Retinitis punctata albescens47
HP:0000572HP:0000572Visual loss0RP1L1 CL E G H9413715946OMIM:613587OCCULT MACULAR DYSTROPHY; OCMD284
HP:0000572HP:0000572Visual loss0RS1 CL E G H624710457OMIM:312700Retinoschisis 1, X-linked, juvenile148
HP:0000572HP:0000572Visual loss0SDCCAG8 CL E G H1080610671ORPHA:3156Senior-Loken syndrome61
HP:0000572HP:0000572Visual loss0SEMA4A CL E G H6421810729OMIM:610283Cone-Rod dystrophy 1048
HP:0000572HP:0000572Visual loss0SF3B1 CL E G H2345110768ORPHA:39044Uveal melanomaHP:0040281 - Very frequent19
HP:0000572HP:0000572Visual loss0SH3BP2 CL E G H645210825ORPHA:184Cherubism177
HP:0000572HP:0000572Visual loss0SLC19A2 CL E G H1056010938OMIM:249270Thiamine-Responsive megaloblastic anemia syndrome.55
HP:0000572HP:0000572Visual loss0SLC19A2 CL E G H1056010938ORPHA:49827Thiamine-responsive megaloblastic anemia syndromeHP:0040283 - Occasional55
HP:0000572HP:0000572Visual loss0SLC25A46 CL E G H9113725198OMIM:616505Neuropathy, hereditary motor and sensory, type VIB14
HP:0000572HP:0000572Visual loss0SLC25A46 CL E G H9113725198ORPHA:2254Pontocerebellar hypoplasia type 114
HP:0000572HP:0000572Visual loss0SLC4A11 CL E G H8395916438ORPHA:98974Fuchs endothelial corneal dystrophy66
HP:0000572HP:0000572Visual loss0SLC52A2 CL E G H7958130224OMIM:614707Brown-Vialetto-Van laere syndrome 2HP:0040283 - Occasional47
HP:0000572HP:0000572Visual loss0SMARCB1 CL E G H659811103ORPHA:2495Meningioma87
HP:0000572HP:0000572Visual loss0SMARCE1 CL E G H660511109ORPHA:2495Meningioma47
HP:0000572HP:0000572Visual loss0SMCHD1 CL E G H2334729090ORPHA:2250Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndromeHP:0040282 - Frequent174
HP:0000572HP:0000572Visual loss0SMO CL E G H660811119ORPHA:2495Meningioma22
HP:0000572HP:0000572Visual loss0SON CL E G H665111183ORPHA:500150Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome12
HP:0000572HP:0000572Visual loss0SOST CL E G H5096413771OMIM:122860Craniodiaphyseal dysplasia, autosomal dominant26
HP:0000572HP:0000572Visual loss0SOST CL E G H5096413771OMIM:269500Sclerosteosis 1.26
HP:0000572HP:0000572Visual loss0SOX2 CL E G H665711195ORPHA:77298Anophthalmia/microphthalmia-esophageal atresia syndromeHP:0040282 - Frequent33
HP:0000572HP:0000572Visual loss0SPATA7 CL E G H5581220423OMIM:604232LEBER CONGENITAL AMAUROSIS 3; LCA348
HP:0000572HP:0000572Visual loss0SPTBN1 CL E G H671111275OMIM:619475DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES; DDISBA
HP:0000572HP:0000572Visual loss0SRD5A3 CL E G H7964425812OMIM:612379Congenital disorder of glycosylation, type IQHP:0040282 - Frequent80
HP:0000572HP:0000572Visual loss0SRD5A3 CL E G H7964425812ORPHA:324737SRD5A3-CDGHP:0040282 - Frequent80
HP:0000572HP:0000572Visual loss0ST3GAL5 CL E G H886910872OMIM:609056Salt and pepper developmental regression syndrome.47
HP:0000572HP:0000572Visual loss0STAT4 CL E G H677511365ORPHA:85410Oligoarticular juvenile idiopathic arthritisHP:0040283 - Occasional2
HP:0000572HP:0000572Visual loss0SUFU CL E G H5168416466ORPHA:2495Meningioma124
HP:0000572HP:0000572Visual loss0TAT CL E G H689811573ORPHA:28378Tyrosinemia type 2HP:0040283 - Occasional43
HP:0000572HP:0000572Visual loss0TBC1D24 CL E G H5746529203OMIM:615338Epileptic encephalopathy, early infantile, 16.271
HP:0000572HP:0000572Visual loss0TCF4 CL E G H692511634ORPHA:98974Fuchs endothelial corneal dystrophy241
HP:0000572HP:0000572Visual loss0TCOF1 CL E G H694911654OMIM:154500Treacher collins-franceschetti syndrome.140
HP:0000572HP:0000572Visual loss0TEK CL E G H701011724ORPHA:98976Congenital glaucomaHP:0040283 - Occasional78
HP:0000572HP:0000572Visual loss0TERT CL E G H701511730ORPHA:2495Meningioma238
HP:0000572HP:0000572Visual loss0TFG CL E G H1034211758OMIM:615658Spastic paraplegia 57, autosomal recessive.18
HP:0000572HP:0000572Visual loss0TGFBI CL E G H704511771OMIM:122200Corneal dystrophy, lattice type I58
HP:0000572HP:0000572Visual loss0TGFBI CL E G H704511771ORPHA:98964Lattice corneal dystrophy type IHP:0040281 - Very frequent58
HP:0000572HP:0000572Visual loss0TGFBI CL E G H704511771ORPHA:98960Thiel-Behnke corneal dystrophy58
HP:0000572HP:0000572Visual loss0TIMM8A CL E G H167811817ORPHA:52368Mohr-Tranebjaerg syndromeHP:0040283 - Occasional15
HP:0000572HP:0000572Visual loss0TIMP3 CL E G H707811822ORPHA:59181Sorsby pseudoinflammatory fundus dystrophyHP:0040281 - Very frequent95
HP:0000572HP:0000572Visual loss0TNFRSF11A CL E G H879211908OMIM:612301OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB772
HP:0000572HP:0000572Visual loss0TPP1 CL E G H12002073OMIM:204500Ceroid lipofuscinosis, neuronal, 2203
HP:0000572HP:0000572Visual loss0TRAF3IP1 CL E G H2614617861ORPHA:3156Senior-Loken syndrome6
HP:0000572HP:0000572Visual loss0TRAF7 CL E G H8423120456ORPHA:2495Meningioma
HP:0000572HP:0000572Visual loss0TREX1 CL E G H1127712269OMIM:192315Vasculopathy, retinal, with cerebral leukodystrophy56
HP:0000572HP:0000572Visual loss0TRIM44 CL E G H5476519016OMIM:617142Aniridia 31
HP:0000572HP:0000572Visual loss0TRIM44 CL E G H5476519016ORPHA:250923Isolated aniridiaHP:0040281 - Very frequent1
HP:0000572HP:0000572Visual loss0TRNF CL E G H45587481ORPHA:550MELASHP:0040282 - Frequent
HP:0000572HP:0000572Visual loss0TRNH CL E G H45647487ORPHA:550MELASHP:0040282 - Frequent
HP:0000572HP:0000572Visual loss0TRNL1 CL E G H45677490ORPHA:550MELASHP:0040282 - Frequent
HP:0000572HP:0000572Visual loss0TRNQ CL E G H45727495ORPHA:550MELASHP:0040282 - Frequent
HP:0000572HP:0000572Visual loss0TRNS1 CL E G H45747497ORPHA:550MELASHP:0040282 - Frequent
HP:0000572HP:0000572Visual loss0TRNS2 CL E G H45757498ORPHA:550MELASHP:0040282 - Frequent
HP:0000572HP:0000572Visual loss0TRNS2 CL E G H45757498ORPHA:231183Usher syndrome type 3HP:0040281 - Very frequent
HP:0000572HP:0000572Visual loss0TRNW CL E G H45787501ORPHA:550MELASHP:0040282 - Frequent
HP:0000572HP:0000572Visual loss0TUBB3 CL E G H1038120772ORPHA:300570Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutationHP:0040283 - Occasional64
HP:0000572HP:0000572Visual loss0UCHL1 CL E G H734512513OMIM:615491Spastic paraplegia 79, autosomal recessive.21
HP:0000572HP:0000572Visual loss0USH1C CL E G H1008312597ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent173
HP:0000572HP:0000572Visual loss0USH1C CL E G H1008312597OMIM:276900Usher syndrome, type I.173
HP:0000572HP:0000572Visual loss0USH1G CL E G H12459016356ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent78
HP:0000572HP:0000572Visual loss0USH2A CL E G H739912601ORPHA:231178Usher syndrome type 2HP:0040281 - Very frequent777
HP:0000572HP:0000572Visual loss0VCAN CL E G H14622464OMIM:143200Wagner vitreoretinopathy.180
HP:0000572HP:0000572Visual loss0VHL CL E G H742812687ORPHA:892Von Hippel-Lindau diseaseHP:0040283 - Occasional490
HP:0000572HP:0000572Visual loss0VRK1 CL E G H744312718ORPHA:2254Pontocerebellar hypoplasia type 132
HP:0000572HP:0000572Visual loss0WAC CL E G H5132217327ORPHA:466950Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutationHP:0040283 - Occasional20
HP:0000572HP:0000572Visual loss0WDR19 CL E G H5772818340ORPHA:3156Senior-Loken syndrome95
HP:0000572HP:0000572Visual loss0WHRN CL E G H2586116361ORPHA:231178Usher syndrome type 2HP:0040281 - Very frequent155
HP:0000572HP:0000572Visual loss0XYLT2 CL E G H6413215517ORPHA:85194Spondylo-ocular syndromeHP:0040281 - Very frequent5
HP:0000572HP:0000572Visual loss0ZEB1 CL E G H693511642ORPHA:98974Fuchs endothelial corneal dystrophy8
HP:0000572HP:0000572Visual loss0ZNF408 CL E G H7979720041OMIM:616468Exudative vitreoretinopathy 614
HP:0000572HP:0000572Visual loss0ZNF469 CL E G H8462723216OMIM:229200Brittle cornea syndrome.397
HP:0000572HP:0000572Visual loss0ZNF469 CL E G H8462723216ORPHA:90354Brittle cornea syndromeHP:0040282 - Frequent397
HP:0000572HP:0000572Visual loss0ZNHIT3 CL E G H932612309ORPHA:2836PEHO syndromeHP:0040281 - Very frequent1
HP:0000572HP:0000529Progressive visual loss1AGTPBP1 CL E G H2328717258ORPHA:2254Pontocerebellar hypoplasia type 11
HP:0000572HP:0000529Progressive visual loss1AIP CL E G H9049358ORPHA:2965ProlactinomaHP:0040282 - Frequent95
HP:0000572HP:0000529Progressive visual loss1AKT1 CL E G H207391ORPHA:2495Meningioma54
HP:0000572HP:0000529Progressive visual loss1APOE CL E G H348613OMIM:603075Macular degeneration, age-related, 139
HP:0000572HP:0000529Progressive visual loss1ARL3 CL E G H403694OMIM:618161JOUBERT SYNDROME 35; JBTS351
HP:0000572HP:0000529Progressive visual loss1ATP1A3 CL E G H478801OMIM:601338Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss.150
HP:0000572HP:0000529Progressive visual loss1ATP6 CL E G H45087414ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000529Progressive visual loss1ATXN7 CL E G H631410560OMIM:164500Spinocerebellar ataxia 7 opca III opca with retinal degeneration opca with macular degeneration and external ophthalmoplegia autosomal dominant cerebellar ataxia, type II adca, type II.8
HP:0000572HP:0000529Progressive visual loss1BAP1 CL E G H8314950ORPHA:2495Meningioma184
HP:0000572HP:0000529Progressive visual loss1BRAF CL E G H6731097OMIM:115150Cardiofaciocutaneous syndrome 1.276
HP:0000572HP:0000529Progressive visual loss1BRAF CL E G H6731097ORPHA:54595Craniopharyngioma276
HP:0000572HP:0200068Nonprogressive visual loss1BTD CL E G H6861122ORPHA:79241Biotinidase deficiencyHP:0040283 - Occasional223
HP:0000572HP:0000529Progressive visual loss1C19ORF12 CL E G H8363625443OMIM:614298Neurodegeneration with brain iron accumulation 4.114
HP:0000572HP:0000529Progressive visual loss1CARS2 CL E G H7958725695ORPHA:477774Combined oxidative phosphorylation defect type 27HP:0040282 - Frequent35
HP:0000572HP:0000529Progressive visual loss1CDH23 CL E G H6407213733ORPHA:2965ProlactinomaHP:0040282 - Frequent636
HP:0000572HP:0000529Progressive visual loss1CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenomaHP:0040282 - Frequent636
HP:0000572HP:0000529Progressive visual loss1CDHR1 CL E G H9221114550OMIM:613660CONE-ROD DYSTROPHY 15; CORD15147
HP:0000572HP:0000529Progressive visual loss1CEP164 CL E G H2289729182ORPHA:3156Senior-Loken syndromeHP:0040282 - Frequent34
HP:0000572HP:0000529Progressive visual loss1CEP290 CL E G H8018429021ORPHA:3156Senior-Loken syndromeHP:0040282 - Frequent342
HP:0000572HP:0000529Progressive visual loss1CFAP418 CL E G H15765727232OMIM:614500Cone-Rod dystrophy 16
HP:0000572HP:0000529Progressive visual loss1CFH CL E G H30754883OMIM:126700Basal laminar drusen.86
HP:0000572HP:0000529Progressive visual loss1CFHR1 CL E G H30784888OMIM:603075Macular degeneration, age-related, 1
HP:0000572HP:0000529Progressive visual loss1CFHR3 CL E G H1087816980OMIM:603075Macular degeneration, age-related, 1
HP:0000572HP:0000529Progressive visual loss1CFI CL E G H34265394OMIM:615439Macular degeneration, age-related, 13.57
HP:0000572HP:0000529Progressive visual loss1CHM CL E G H11211940ORPHA:180ChoroideremiaHP:0040282 - Frequent47
HP:0000572HP:0000529Progressive visual loss1CHM CL E G H11211940OMIM:303100CHOROIDEREMIA.47
HP:0000572HP:0000529Progressive visual loss1CLN3 CL E G H12012074OMIM:204200Ceroid lipofuscinosis, neuronal, 3.216
HP:0000572HP:0000529Progressive visual loss1CLN3 CL E G H12012074ORPHA:228346CLN3 disease216
HP:0000572HP:0000529Progressive visual loss1CLN5 CL E G H12032076OMIM:256731Ceroid lipofuscinosis, neuronal, 5.141
HP:0000572HP:0000529Progressive visual loss1CLN6 CL E G H549822077OMIM:601780Ceroid lipofuscinosis, neuronal, 6.143
HP:0000572HP:0000529Progressive visual loss1CLN8 CL E G H20552079OMIM:600143Ceroid lipofuscinosis, neuronal, 8.111
HP:0000572HP:0000529Progressive visual loss1CLN8 CL E G H20552079ORPHA:1947Progressive epilepsy-intellectual disability syndrome, Finnish typeHP:0040282 - Frequent111
HP:0000572HP:0000529Progressive visual loss1COL17A1 CL E G H13082194ORPHA:293381Epithelial recurrent erosion dystrophyHP:0040281 - Very frequent129
HP:0000572HP:0000529Progressive visual loss1COL18A1 CL E G H807812195ORPHA:1571Knobloch syndromeHP:0040282 - Frequent177
HP:0000572HP:0000529Progressive visual loss1COX1 CL E G H45127419ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000529Progressive visual loss1COX3 CL E G H45147422ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000529Progressive visual loss1CTNNB1 CL E G H14992514ORPHA:54595Craniopharyngioma88
HP:0000572HP:0000529Progressive visual loss1CYP4V2 CL E G H28544023198OMIM:210370Bietti crystalline corneoretinal dystrophy.126
HP:0000572HP:0000529Progressive visual loss1CYTB CL E G H45197427ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000529Progressive visual loss1DCN CL E G H16342705OMIM:610048Corneal dystrophy, congenital stromal.31
HP:0000572HP:0000529Progressive visual loss1DNAJC30 CL E G H8427716410ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000529Progressive visual loss1DNM1L CL E G H100592973OMIM:610708Optic atrophy 594
HP:0000572HP:0000529Progressive visual loss1EPRS1 CL E G H20583418OMIM:617951Leukodystrophy, hypomyelinating, 15.
HP:0000572HP:0000529Progressive visual loss1EXOSC3 CL E G H5101017944ORPHA:2254Pontocerebellar hypoplasia type 138
HP:0000572HP:0000529Progressive visual loss1EXOSC8 CL E G H1134017035ORPHA:2254Pontocerebellar hypoplasia type 14
HP:0000572HP:0000529Progressive visual loss1EXOSC9 CL E G H53939137ORPHA:2254Pontocerebellar hypoplasia type 1
HP:0000572HP:0000529Progressive visual loss1FA2H CL E G H7915221197ORPHA:329308Fatty acid hydroxylase-associated neurodegeneration76
HP:0000572HP:0000529Progressive visual loss1GUCA1A CL E G H29784678ORPHA:75377Central areolar choroidal dystrophy24
HP:0000572HP:0000529Progressive visual loss1GUCA1A CL E G H29784678OMIM:602093Cone dystrophy 3.24
HP:0000572HP:0000529Progressive visual loss1GUCY2D CL E G H30004689ORPHA:75377Central areolar choroidal dystrophy124
HP:0000572HP:0000529Progressive visual loss1HMCN1 CL E G H8387219194OMIM:603075Macular degeneration, age-related, 1262
HP:0000572HP:0000529Progressive visual loss1IFT140 CL E G H974229077OMIM:617781Retinitis pigmentosa 80.148
HP:0000572HP:0000529Progressive visual loss1INVS CL E G H2713017870ORPHA:3156Senior-Loken syndromeHP:0040282 - Frequent106
HP:0000572HP:0000529Progressive visual loss1IQCB1 CL E G H965728949ORPHA:3156Senior-Loken syndromeHP:0040282 - Frequent61
HP:0000572HP:0000529Progressive visual loss1KARS1 CL E G H37356215OMIM:619196DEAFNESS, CONGENITAL, AND ADULT-ONSET PROGRESSIVE LEUKOENCEPHALOPATHY; DEAPLE
HP:0000572HP:0000529Progressive visual loss1KIAA1549 CL E G H5767022219OMIM:618613RETINITIS PIGMENTOSA 86; RP86
HP:0000572HP:0000529Progressive visual loss1LRP2 CL E G H40366694OMIM:222448Donnai-Barrow syndrome289
HP:0000572HP:0000529Progressive visual loss1LRP2 CL E G H40366694ORPHA:2143Donnai-Barrow syndromeHP:0040282 - Frequent289
HP:0000572HP:0000529Progressive visual loss1MEN1 CL E G H42217010ORPHA:2965ProlactinomaHP:0040282 - Frequent462
HP:0000572HP:0000529Progressive visual loss1MERTK CL E G H104617027OMIM:613862Retinitis pigmentosa 38.75
HP:0000572HP:0000529Progressive visual loss1MFN2 CL E G H992716877OMIM:601152Hereditary motor and sensory neuropathy VI203
HP:0000572HP:0000529Progressive visual loss1MTTP CL E G H45477467ORPHA:14AbetalipoproteinemiaHP:0040282 - Frequent81
HP:0000572HP:0200068Nonprogressive visual loss1NBAS CL E G H5159415625OMIM:614800Short stature, optic nerve atrophy, and pelger-huet anomaly.25
HP:0000572HP:0000529Progressive visual loss1ND1 CL E G H45357455ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000529Progressive visual loss1ND2 CL E G H45367456ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000529Progressive visual loss1ND4 CL E G H45387459ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000529Progressive visual loss1ND4L CL E G H45397460ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000529Progressive visual loss1ND5 CL E G H45407461ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000529Progressive visual loss1ND6 CL E G H45417462ORPHA:104Leber hereditary optic neuropathy
HP:0000572HP:0000529Progressive visual loss1NDUFS2 CL E G H47207708ORPHA:104Leber hereditary optic neuropathy65
HP:0000572HP:0000529Progressive visual loss1NEU1 CL E G H47587758OMIM:256550Neuraminidase deficiency.43
HP:0000572HP:0000529Progressive visual loss1NEU1 CL E G H47587758ORPHA:812Sialidosis type 1HP:0040281 - Very frequent43
HP:0000572HP:0000529Progressive visual loss1NF1 CL E G H47637765ORPHA:9768517q11 microdeletion syndromeHP:0040282 - Frequent1952
HP:0000572HP:0000529Progressive visual loss1NF2 CL E G H47717773ORPHA:2495Meningioma220
HP:0000572HP:0000529Progressive visual loss1NPHP1 CL E G H48677905ORPHA:3156Senior-Loken syndromeHP:0040282 - Frequent85
HP:0000572HP:0000529Progressive visual loss1NPHP3 CL E G H270317907ORPHA:3156Senior-Loken syndromeHP:0040282 - Frequent157
HP:0000572HP:0000529Progressive visual loss1NPHP4 CL E G H26173419104ORPHA:3156Senior-Loken syndromeHP:0040282 - Frequent220
HP:0000572HP:0000529Progressive visual loss1OAT CL E G H49428091ORPHA:414Gyrate atrophy of choroid and retinaHP:0040281 - Very frequent94
HP:0000572HP:0000529Progressive visual loss1OPA1 CL E G H49768140ORPHA:1215Autosomal dominant optic atrophy plus syndromeHP:0040281 - Very frequent214
HP:0000572HP:0000529Progressive visual loss1OPA1 CL E G H49768140OMIM:210000Behr syndrome.214
HP:0000572HP:0000529Progressive visual loss1PAK2 CL E G H50628591ORPHA:1571Knobloch syndromeHP:0040282 - Frequent
HP:0000572HP:0000529Progressive visual loss1PCYT1A CL E G H51308754OMIM:608940Spondylometaphyseal dysplasia with cone-rod dystrophy.11
HP:0000572HP:0000529Progressive visual loss1PDGFB CL E G H51558800ORPHA:2495Meningioma9
HP:0000572HP:0000529Progressive visual loss1PEX7 CL E G H51918860ORPHA:773Refsum diseaseHP:0040283 - Occasional72
HP:0000572HP:0000529Progressive visual loss1PHYH CL E G H52648940ORPHA:773Refsum diseaseHP:0040283 - Occasional45
HP:0000572HP:0000529Progressive visual loss1PIK3CA CL E G H52908975ORPHA:2495Meningioma162
HP:0000572HP:0000529Progressive visual loss1PNPLA6 CL E G H1090816268OMIM:215470Boucher-Neuhauser syndrome103
HP:0000572HP:0000529Progressive visual loss1PPT1 CL E G H55389325OMIM:256730Ceroid lipofuscinosis, neuronal, 1.172
HP:0000572HP:0000529Progressive visual loss1PRPH2 CL E G H59619942ORPHA:75377Central areolar choroidal dystrophy159
HP:0000572HP:0000529Progressive visual loss1PRPH2 CL E G H59619942ORPHA:52427Retinitis punctata albescensHP:0040281 - Very frequent159
HP:0000572HP:0000529Progressive visual loss1PRPS1 CL E G H56319462OMIM:311070Charcot-Marie-Tooth disease, X-linked recessive, 549
HP:0000572HP:0000529Progressive visual loss1RAX2 CL E G H8483918286OMIM:610381Cone-Rod dystrophy 1152
HP:0000572HP:0000529Progressive visual loss1RDH11 CL E G H5110917964ORPHA:436245Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndromeHP:0040281 - Very frequent2
HP:0000572HP:0000529Progressive visual loss1RDH5 CL E G H59599940ORPHA:52427Retinitis punctata albescensHP:0040281 - Very frequent32
HP:0000572HP:0000529Progressive visual loss1RHO CL E G H601010012ORPHA:52427Retinitis punctata albescensHP:0040281 - Very frequent107
HP:0000572HP:0000529Progressive visual loss1RLBP1 CL E G H601710024ORPHA:85128Bothnia retinal dystrophyHP:0040281 - Very frequent47
HP:0000572HP:0000529Progressive visual loss1RLBP1 CL E G H601710024ORPHA:52427Retinitis punctata albescensHP:0040281 - Very frequent47
HP:0000572HP:0000529Progressive visual loss1RP1L1 CL E G H9413715946OMIM:613587OCCULT MACULAR DYSTROPHY; OCMD284
HP:0000572HP:0000529Progressive visual loss1RS1 CL E G H624710457OMIM:312700Retinoschisis 1, X-linked, juvenile148
HP:0000572HP:0000529Progressive visual loss1SDCCAG8 CL E G H1080610671ORPHA:3156Senior-Loken syndromeHP:0040282 - Frequent61
HP:0000572HP:0000529Progressive visual loss1SEMA4A CL E G H6421810729OMIM:610283Cone-Rod dystrophy 10.48
HP:0000572HP:0000529Progressive visual loss1SH3BP2 CL E G H645210825ORPHA:184CherubismHP:0040283 - Occasional177
HP:0000572HP:0000529Progressive visual loss1SLC25A46 CL E G H9113725198OMIM:616505Neuropathy, hereditary motor and sensory, type VIB.14
HP:0000572HP:0000529Progressive visual loss1SLC25A46 CL E G H9113725198ORPHA:2254Pontocerebellar hypoplasia type 114
HP:0000572HP:0000529Progressive visual loss1SMARCB1 CL E G H659811103ORPHA:2495Meningioma87
HP:0000572HP:0000529Progressive visual loss1SMARCE1 CL E G H660511109ORPHA:2495Meningioma47
HP:0000572HP:0000529Progressive visual loss1SMO CL E G H660811119ORPHA:2495Meningioma22
HP:0000572HP:0000529Progressive visual loss1SON CL E G H665111183ORPHA:500150Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndromeHP:0040283 - Occasional12
HP:0000572HP:0000529Progressive visual loss1SOST CL E G H5096413771OMIM:122860Craniodiaphyseal dysplasia, autosomal dominant.26
HP:0000572HP:0000529Progressive visual loss1SUFU CL E G H5168416466ORPHA:2495Meningioma124
HP:0000572HP:0000529Progressive visual loss1TERT CL E G H701511730ORPHA:2495Meningioma238
HP:0000572HP:0000529Progressive visual loss1TGFBI CL E G H704511771OMIM:122200Corneal dystrophy, lattice type I.58
HP:0000572HP:0000529Progressive visual loss1TGFBI CL E G H704511771ORPHA:98964Lattice corneal dystrophy type I58
HP:0000572HP:0000529Progressive visual loss1TGFBI CL E G H704511771ORPHA:98960Thiel-Behnke corneal dystrophy58
HP:0000572HP:0000529Progressive visual loss1TNFRSF11A CL E G H879211908OMIM:612301OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB772
HP:0000572HP:0000529Progressive visual loss1TPP1 CL E G H12002073OMIM:204500Ceroid lipofuscinosis, neuronal, 2.203
HP:0000572HP:0000529Progressive visual loss1TRAF3IP1 CL E G H2614617861ORPHA:3156Senior-Loken syndromeHP:0040282 - Frequent6
HP:0000572HP:0000529Progressive visual loss1TRAF7 CL E G H8423120456ORPHA:2495Meningioma
HP:0000572HP:0000529Progressive visual loss1TREX1 CL E G H1127712269OMIM:192315Vasculopathy, retinal, with cerebral leukodystrophy.56
HP:0000572HP:0000529Progressive visual loss1TRIM44 CL E G H5476519016OMIM:617142Aniridia 3.1
HP:0000572HP:0000529Progressive visual loss1UCHL1 CL E G H734512513OMIM:615491Spastic paraplegia 79, autosomal recessive.21
HP:0000572HP:0000529Progressive visual loss1VRK1 CL E G H744312718ORPHA:2254Pontocerebellar hypoplasia type 132
HP:0000572HP:0000529Progressive visual loss1WDR19 CL E G H5772818340ORPHA:3156Senior-Loken syndromeHP:0040282 - Frequent95
HP:0000572HP:0000529Progressive visual loss1ZNF408 CL E G H7979720041OMIM:616468Exudative vitreoretinopathy 6.14
HP:0000572HP:0007924Slow decrease in visual acuity2AKT1 CL E G H207391ORPHA:2495MeningiomaHP:0040283 - Occasional54
HP:0000572HP:0007924Slow decrease in visual acuity2ATP6 CL E G H45087414ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000572HP:0007924Slow decrease in visual acuity2BAP1 CL E G H8314950ORPHA:2495MeningiomaHP:0040283 - Occasional184
HP:0000572HP:0007924Slow decrease in visual acuity2BRAF CL E G H6731097ORPHA:54595CraniopharyngiomaHP:0040282 - Frequent276
HP:0000572HP:0007924Slow decrease in visual acuity2COX1 CL E G H45127419ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000572HP:0007924Slow decrease in visual acuity2COX3 CL E G H45147422ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000572HP:0007924Slow decrease in visual acuity2CTNNB1 CL E G H14992514ORPHA:54595CraniopharyngiomaHP:0040282 - Frequent88
HP:0000572HP:0007924Slow decrease in visual acuity2CYTB CL E G H45197427ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000572HP:0007924Slow decrease in visual acuity2DNAJC30 CL E G H8427716410ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000572HP:0007924Slow decrease in visual acuity2DNM1L CL E G H100592973OMIM:610708Optic atrophy 5.94
HP:0000572HP:0007924Slow decrease in visual acuity2FA2H CL E G H7915221197ORPHA:329308Fatty acid hydroxylase-associated neurodegenerationHP:0040282 - Frequent76
HP:0000572HP:0007924Slow decrease in visual acuity2GUCA1A CL E G H29784678ORPHA:75377Central areolar choroidal dystrophyHP:0040282 - Frequent24
HP:0000572HP:0007924Slow decrease in visual acuity2GUCY2D CL E G H30004689ORPHA:75377Central areolar choroidal dystrophyHP:0040282 - Frequent124
HP:0000572HP:0007924Slow decrease in visual acuity2MFN2 CL E G H992716877OMIM:601152Hereditary motor and sensory neuropathy VI.203
HP:0000572HP:0007924Slow decrease in visual acuity2ND1 CL E G H45357455ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000572HP:0007924Slow decrease in visual acuity2ND2 CL E G H45367456ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000572HP:0007924Slow decrease in visual acuity2ND4 CL E G H45387459ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000572HP:0007924Slow decrease in visual acuity2ND4L CL E G H45397460ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000572HP:0007924Slow decrease in visual acuity2ND5 CL E G H45407461ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000572HP:0007924Slow decrease in visual acuity2ND6 CL E G H45417462ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000572HP:0007924Slow decrease in visual acuity2NDUFS2 CL E G H47207708ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent65
HP:0000572HP:0007924Slow decrease in visual acuity2NF2 CL E G H47717773ORPHA:2495MeningiomaHP:0040283 - Occasional220
HP:0000572HP:0007924Slow decrease in visual acuity2PDGFB CL E G H51558800ORPHA:2495MeningiomaHP:0040283 - Occasional9
HP:0000572HP:0007924Slow decrease in visual acuity2PIK3CA CL E G H52908975ORPHA:2495MeningiomaHP:0040283 - Occasional162
HP:0000572HP:0007924Slow decrease in visual acuity2PRPH2 CL E G H59619942ORPHA:75377Central areolar choroidal dystrophyHP:0040282 - Frequent159
HP:0000572HP:0007924Slow decrease in visual acuity2RAX2 CL E G H8483918286OMIM:610381Cone-Rod dystrophy 11.52
HP:0000572HP:0007924Slow decrease in visual acuity2RP1L1 CL E G H9413715946OMIM:613587OCCULT MACULAR DYSTROPHY; OCMD284
HP:0000572HP:0007924Slow decrease in visual acuity2SMARCB1 CL E G H659811103ORPHA:2495MeningiomaHP:0040283 - Occasional87
HP:0000572HP:0007924Slow decrease in visual acuity2SMARCE1 CL E G H660511109ORPHA:2495MeningiomaHP:0040283 - Occasional47
HP:0000572HP:0007924Slow decrease in visual acuity2SMO CL E G H660811119ORPHA:2495MeningiomaHP:0040283 - Occasional22
HP:0000572HP:0007924Slow decrease in visual acuity2SUFU CL E G H5168416466ORPHA:2495MeningiomaHP:0040283 - Occasional124
HP:0000572HP:0007924Slow decrease in visual acuity2TERT CL E G H701511730ORPHA:2495MeningiomaHP:0040283 - Occasional238
HP:0000572HP:0007924Slow decrease in visual acuity2TGFBI CL E G H704511771ORPHA:98964Lattice corneal dystrophy type IHP:0040283 - Occasional58
HP:0000572HP:0007924Slow decrease in visual acuity2TGFBI CL E G H704511771ORPHA:98960Thiel-Behnke corneal dystrophyHP:0040281 - Very frequent58
HP:0000572HP:0007924Slow decrease in visual acuity2TRAF7 CL E G H8423120456ORPHA:2495MeningiomaHP:0040283 - Occasional


Genes (239) :ABCA4 ABCD1 ADAMTS10 ADGRV1 AGBL1 AGTPBP1 AHI1 AIP AKT1 ALMS1 ALPK1 ANKRD55 APOE ARL3 ARSG ATP1A3 ATP6 ATXN7 BAP1 BCOR BRAF BTD C19ORF12 C1QTNF5 CA2 CARS2 CCND1 CD247 CDH23 CDHR1 CEP120 CEP164 CEP290 CEP41 CEP78 CFAP418 CFH CFHR1 CFHR3 CFI CHM CIB2 CLCN7 CLN3 CLN5 CLN6 CLN8 CLRN1 COL17A1 COL18A1 COL2A1 COL7A1 COL8A2 COQ2 COX1 COX2 COX3 COX6B1 COX7B CSPP1 CTNNB1 CTSD CYP1B1 CYP4V2 CYSLTR2 CYTB DCN DNAJC30 DNM1L EFEMP1 ELMO2 EPM2A EPRS1 ESPN EXOSC3 EXOSC8 EXOSC9 FA2H FBN1 FGFR2 FLVCR1 FOXC1 GALC GATA2 GJB2 GJB6 GNA11 GNAQ GNAS GUCA1A GUCY2D HADHA HARS1 HCCS HLA-A HLA-B HLA-DRB1 HMCN1 HSD17B10 HSD17B4 IFT140 IL2RA IL2RB INPP5E INVS IQCB1 KARS1 KCTD7 KIAA0586 KIAA1549 KIF11 KIF1A LAMC3 LCA5 LRP2 LSS LTBP2 MEN1 MERTK MFN2 MFSD8 MKS1 MMP1 MTTP MYO7A MYOC NBAS ND1 ND2 ND4 ND4L ND5 ND6 NDUFB11 NDUFS2 NEU1 NF1 NF2 NHLRC1 NHS NOD2 NOTCH3 NPHP1 NPHP3 NPHP4 OAT OPA1 P4HA2 PAK2 PAX6 PCDH15 PCYT1A PDGFB PDZD7 PEX13 PEX7 PGK1 PHYH PIK3CA PLA2G6 PMPCB PNPLA6 POLA1 POLG POLG2 PPT1 PRDM5 PRPH2 PRPS1 PSAP PTPN2 PTPN22 RAX2 RDH11 RDH5 RHO RLBP1 RP1L1 RS1 SDCCAG8 SEMA4A SF3B1 SH3BP2 SLC19A2 SLC25A46 SLC4A11 SLC52A2 SMARCB1 SMARCE1 SMCHD1 SMO SON SOST SOX2 SPATA7 SPTBN1 SRD5A3 ST3GAL5 STAT4 SUFU TAT TBC1D24 TCF4 TCOF1 TEK TERT TFG TGFBI TIMM8A TIMP3 TNFRSF11A TPP1 TRAF3IP1 TRAF7 TREX1 TRIM44 TRNF TRNH TRNL1 TRNQ TRNS1 TRNS2 TRNW TUBB3 UCHL1 USH1C USH1G USH2A VCAN VHL VRK1 WAC WDR19 WHRN XYLT2 ZEB1 ZNF408 ZNF469 ZNHIT3

Diseases (173) :OMIM:604116 OMIM:300100 ORPHA:3449 ORPHA:231178 ORPHA:98974 ORPHA:2254 ORPHA:220493 ORPHA:2965 ORPHA:2495 ORPHA:64 OMIM:203800 OMIM:614979 ORPHA:85410 OMIM:603075 OMIM:618161 ORPHA:231183 OMIM:601338 ORPHA:104 OMIM:535000 OMIM:164500 ORPHA:94147 ORPHA:39044 OMIM:300166 OMIM:115150 ORPHA:54595 ORPHA:79241 OMIM:253260 OMIM:614298 ORPHA:67042 OMIM:605670 OMIM:259730 ORPHA:477774 ORPHA:892 ORPHA:91347 ORPHA:231169 OMIM:613660 ORPHA:3156 OMIM:614500 OMIM:126700 ORPHA:75376 OMIM:615439 ORPHA:180 OMIM:303100 OMIM:166600 OMIM:204200 ORPHA:228346 OMIM:256731 OMIM:601780 OMIM:600143 ORPHA:1947 ORPHA:293381 ORPHA:1571 ORPHA:90653 ORPHA:89842 ORPHA:79408 OMIM:607426 ORPHA:550 OMIM:619051 ORPHA:2556 ORPHA:397715 OMIM:610127 ORPHA:98976 OMIM:210370 OMIM:610048 OMIM:610708 OMIM:606893 OMIM:254780 OMIM:617951 ORPHA:329308 ORPHA:93259 ORPHA:88628 ORPHA:250923 ORPHA:206448 ORPHA:206436 ORPHA:206443 ORPHA:3226 ORPHA:477 ORPHA:562 ORPHA:75377 OMIM:602093 ORPHA:5 ORPHA:179 ORPHA:397 ORPHA:391428 OMIM:300438 OMIM:261515 OMIM:617781 OMIM:266920 OMIM:619196 OMIM:611726 OMIM:618613 ORPHA:2526 ORPHA:2836 OMIM:614115 OMIM:604537 ORPHA:2143 OMIM:222448 OMIM:616509 OMIM:613862 OMIM:601152 OMIM:610951 ORPHA:14 OMIM:276900 OMIM:614800 ORPHA:93400 ORPHA:93399 OMIM:256550 ORPHA:812 ORPHA:97685 ORPHA:637 OMIM:302350 ORPHA:627 ORPHA:90340 OMIM:125310 ORPHA:414 ORPHA:1215 OMIM:210000 OMIM:608940 OMIM:614885 ORPHA:773 OMIM:300653 OMIM:256600 OMIM:617954 OMIM:215470 OMIM:301220 OMIM:203700 OMIM:619425 OMIM:256730 ORPHA:90354 ORPHA:52427 OMIM:301835 OMIM:311070 OMIM:610381 ORPHA:436245 ORPHA:85128 OMIM:613587 OMIM:312700 OMIM:610283 ORPHA:184 OMIM:249270 ORPHA:49827 OMIM:616505 OMIM:614707 ORPHA:2250 ORPHA:500150 OMIM:122860 OMIM:269500 ORPHA:77298 OMIM:604232 OMIM:619475 OMIM:612379 ORPHA:324737 OMIM:609056 ORPHA:28378 OMIM:615338 OMIM:154500 OMIM:615658 OMIM:122200 ORPHA:98964 ORPHA:98960 ORPHA:52368 ORPHA:59181 OMIM:612301 OMIM:204500 OMIM:192315 OMIM:617142 ORPHA:300570 OMIM:615491 OMIM:143200 ORPHA:466950 ORPHA:85194 OMIM:616468 OMIM:229200
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.